ATE450273T1 - Proliferationshemmendes arzneimittel - Google Patents
Proliferationshemmendes arzneimittelInfo
- Publication number
- ATE450273T1 ATE450273T1 AT06763171T AT06763171T ATE450273T1 AT E450273 T1 ATE450273 T1 AT E450273T1 AT 06763171 T AT06763171 T AT 06763171T AT 06763171 T AT06763171 T AT 06763171T AT E450273 T1 ATE450273 T1 AT E450273T1
- Authority
- AT
- Austria
- Prior art keywords
- proliferation drug
- proliferation
- drug
- conjugates
- esterified
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
- A61K31/728—Hyaluronic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IE20050328 | 2005-05-18 | ||
| PCT/EP2006/062388 WO2006122954A2 (en) | 2005-05-18 | 2006-05-17 | Antiproliferative conjugates comprising hyaluronic acid and n-derivatives of glutamic acid |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE450273T1 true ATE450273T1 (de) | 2009-12-15 |
Family
ID=37027872
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT06763171T ATE450273T1 (de) | 2005-05-18 | 2006-05-17 | Proliferationshemmendes arzneimittel |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20080200428A1 (de) |
| EP (1) | EP1888069B1 (de) |
| JP (1) | JP2008540790A (de) |
| CN (1) | CN101227906A (de) |
| AT (1) | ATE450273T1 (de) |
| AU (1) | AU2006248966A1 (de) |
| CA (1) | CA2609069A1 (de) |
| DE (1) | DE602006010852D1 (de) |
| ES (1) | ES2337726T3 (de) |
| WO (1) | WO2006122954A2 (de) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5001645B2 (ja) * | 2004-04-02 | 2012-08-15 | 電気化学工業株式会社 | ヒアルロン酸−メトトレキサート結合体 |
| IE20060049A1 (en) * | 2006-01-25 | 2007-08-08 | Eurand Pharmaceuticals Ltd | A novel drug delivery system: use of hyaluronic acid as a carrier moleclue for different classes of therapeutic active agents |
| IE20070900A1 (en) * | 2007-12-12 | 2009-06-24 | Eurand Pharmaceuticals Ltd | New anticancer conjugates |
| ITMI20072416A1 (it) * | 2007-12-21 | 2009-06-22 | Sigea Srl | Derivati polisaccaridici dell'acido lipoico, loro preparazione ed uso come dermocosmetici e presidi medicali |
| WO2021262579A1 (en) * | 2020-06-23 | 2021-12-30 | President And Fellows Of Harvard College | Compositions and methods relating to combinatorial hyaluronic acid conjugates |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4018181B2 (ja) * | 1995-11-07 | 2007-12-05 | 生化学工業株式会社 | グリコサミノグリカン誘導体およびその製造法 |
| IT1318403B1 (it) * | 2000-03-17 | 2003-08-25 | Cooperativa Ct Ricerche Poly T | Esteri polisaccaridici di n-derivati di acido glutammico. |
| US6673919B2 (en) * | 2001-03-30 | 2004-01-06 | Chisso Cororation | Chemically modified hyaluronic acid or salts thereof, and a process for producing thereof |
| JP2004018750A (ja) * | 2002-06-18 | 2004-01-22 | Seikagaku Kogyo Co Ltd | 親水性を向上したヒアルロン酸誘導体の製造方法 |
| EP2497785B1 (de) * | 2004-01-07 | 2018-09-12 | Seikagaku Corporation | Hyaluronsäurederivat und dieses enthaltendes Arzneimittel |
| JP4927536B2 (ja) * | 2004-03-05 | 2012-05-09 | 電気化学工業株式会社 | ヒアルロン酸−メトトレキサート結合体 |
-
2006
- 2006-05-17 CA CA002609069A patent/CA2609069A1/en not_active Abandoned
- 2006-05-17 ES ES06763171T patent/ES2337726T3/es active Active
- 2006-05-17 AT AT06763171T patent/ATE450273T1/de not_active IP Right Cessation
- 2006-05-17 JP JP2008511702A patent/JP2008540790A/ja active Pending
- 2006-05-17 EP EP06763171A patent/EP1888069B1/de active Active
- 2006-05-17 AU AU2006248966A patent/AU2006248966A1/en not_active Abandoned
- 2006-05-17 CN CNA2006800161505A patent/CN101227906A/zh active Pending
- 2006-05-17 DE DE602006010852T patent/DE602006010852D1/de active Active
- 2006-05-17 WO PCT/EP2006/062388 patent/WO2006122954A2/en not_active Application Discontinuation
- 2006-05-17 US US11/914,671 patent/US20080200428A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| JP2008540790A (ja) | 2008-11-20 |
| EP1888069B1 (de) | 2009-12-02 |
| WO2006122954A3 (en) | 2007-03-15 |
| DE602006010852D1 (de) | 2010-01-14 |
| EP1888069A2 (de) | 2008-02-20 |
| AU2006248966A1 (en) | 2006-11-23 |
| US20080200428A1 (en) | 2008-08-21 |
| CA2609069A1 (en) | 2006-11-23 |
| ES2337726T3 (es) | 2010-04-28 |
| CN101227906A (zh) | 2008-07-23 |
| WO2006122954A2 (en) | 2006-11-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA200802008A1 (ru) | Фармацевтические композиции | |
| CY1118452T1 (el) | Ενωσεις και συνθεσεις ως αναστολεις πρωτεϊνικης κινασης | |
| LTPA2018502I1 (lt) | Per burną vartojamos kladribino kompozicijos | |
| FR2883179B1 (fr) | Comprime enrobe | |
| EA200870357A1 (ru) | Производные тетрагидроизохинолина для повышения функции памяти | |
| ATE530210T1 (de) | Endoprothesen | |
| NO20075628L (no) | Farmasøytiske formuleringer | |
| NO20091700L (no) | Florizinanaloger som inhibitorer av glukose-ko-transporter 2 | |
| WO2008115469A3 (en) | Role of hedgehog signaling in atherosclerosis and cardiovascular disease | |
| EA200702529A1 (ru) | Фунгицидная комбинация биологически активных веществ | |
| NL1028087A1 (nl) | Sulfonamiderivaten voor de behandeling van ziekten. | |
| DK1957073T3 (da) | Lægemiddel | |
| ITMI20052036A1 (it) | Composizioni farmaceutiche oftalmiche a base di amminoacidi e sodio ialuronato | |
| NL1032915A1 (nl) | Katheterpunt. | |
| NO20082904L (no) | Feksofenadinsupensjonsformulering | |
| CY1116840T1 (el) | Χρηση 24-norudca | |
| FR2924118B1 (fr) | Fragments d'anticorps inhibiteurs de la proteine nef du vih. | |
| ITRM20050179A1 (it) | Composizione impiegabile per il trattamento delle patologie paradontali. | |
| ATE450273T1 (de) | Proliferationshemmendes arzneimittel | |
| EA201070484A1 (ru) | Новые конъюгаты нейртурина для фармацевтического применения | |
| ITTO20060077U1 (it) | Spazzolino da denti. | |
| WO2007086943A3 (en) | Wortmannin conjugates and uses thereof | |
| EA200600590A1 (ru) | Фармацевтические композиции модафинила с модифицированным высвобождением | |
| ATE552832T1 (de) | Antidepressivum-propharmaka | |
| BRPI0417205A (pt) | composições farmacêuticas |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |